VitaStem Ultra (Bacitracin)
Prevention of infection in minor cuts, scrapes, and burns; alternative for tetracycline-sensitive patients (OTC)
CommercialActive
Key Facts
Indication
Prevention of infection in minor cuts, scrapes, and burns; alternative for tetracycline-sensitive patients (OTC)
Phase
Commercial
Status
Active
Company
About ViaDerma
ViaDerma is a private, commercial-stage company focused on the generic drug sector, specifically topical antibiotics. Its core asset is VitaStem, an OTC product powered by proprietary SkinPass™ technology for rapid transdermal delivery of tetracycline hydrochloride. The company targets the consumer health and professional wound care markets with claims of faster healing and superior germ-killing efficacy compared to traditional topicals like bacitracin and Neosporin. It operates as a direct-to-consumer and likely B2B business from Los Angeles.
View full company profile